1. Home
  2. ADMA vs SAIC Comparison

ADMA vs SAIC Comparison

Compare ADMA & SAIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • SAIC
  • Stock Information
  • Founded
  • ADMA 2004
  • SAIC 1969
  • Country
  • ADMA United States
  • SAIC United States
  • Employees
  • ADMA N/A
  • SAIC N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • SAIC EDP Services
  • Sector
  • ADMA Health Care
  • SAIC Technology
  • Exchange
  • ADMA Nasdaq
  • SAIC Nasdaq
  • Market Cap
  • ADMA 5.3B
  • SAIC 6.1B
  • IPO Year
  • ADMA N/A
  • SAIC N/A
  • Fundamental
  • Price
  • ADMA $21.18
  • SAIC $124.20
  • Analyst Decision
  • ADMA Strong Buy
  • SAIC Hold
  • Analyst Count
  • ADMA 4
  • SAIC 8
  • Target Price
  • ADMA $21.25
  • SAIC $149.25
  • AVG Volume (30 Days)
  • ADMA 3.9M
  • SAIC 489.8K
  • Earning Date
  • ADMA 11-07-2024
  • SAIC 12-05-2024
  • Dividend Yield
  • ADMA N/A
  • SAIC 1.19%
  • EPS Growth
  • ADMA N/A
  • SAIC N/A
  • EPS
  • ADMA 0.28
  • SAIC 5.54
  • Revenue
  • ADMA $382,809,000.00
  • SAIC $7,297,000,000.00
  • Revenue This Year
  • ADMA $60.41
  • SAIC $1.48
  • Revenue Next Year
  • ADMA $13.09
  • SAIC $3.04
  • P/E Ratio
  • ADMA $75.56
  • SAIC $22.42
  • Revenue Growth
  • ADMA 63.39
  • SAIC N/A
  • 52 Week Low
  • ADMA $3.60
  • SAIC $112.00
  • 52 Week High
  • ADMA $23.64
  • SAIC $156.34
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 59.66
  • SAIC 31.38
  • Support Level
  • ADMA $18.90
  • SAIC $117.77
  • Resistance Level
  • ADMA $21.70
  • SAIC $126.98
  • Average True Range (ATR)
  • ADMA 1.13
  • SAIC 5.65
  • MACD
  • ADMA 0.08
  • SAIC -2.73
  • Stochastic Oscillator
  • ADMA 51.48
  • SAIC 16.67

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, the company offers engineering, systems integration, and information technology for large government projects and a broad range of services with an emphasis on higher-end technology services. The company's end-to-end enterprise IT offerings span the entire spectrum of customers' IT infrastructure.

Share on Social Networks: